Cargando…

Atorvastatin Improves Plaque Stability in ApoE-Knockout Mice by Regulating Chemokines and Chemokine Receptors

It is well documented that statins protect atherosclerotic patients from inflammatory changes and plaque instability in coronary arteries. However, the underlying mechanisms are not fully understood. Using a previously established mouse model for vulnerable atherosclerotic plaque, we investigated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Peng, Li, Dandan, Hu, Liuhua, Jin, Shuxuan, Yu, Ying, Cai, Zhaohua, Shao, Qin, Shen, Jieyan, Yi, Jing, Xiao, Hua, Shen, Linghong, He, Ben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016207/
https://www.ncbi.nlm.nih.gov/pubmed/24816562
http://dx.doi.org/10.1371/journal.pone.0097009
_version_ 1782315467440914432
author Nie, Peng
Li, Dandan
Hu, Liuhua
Jin, Shuxuan
Yu, Ying
Cai, Zhaohua
Shao, Qin
Shen, Jieyan
Yi, Jing
Xiao, Hua
Shen, Linghong
He, Ben
author_facet Nie, Peng
Li, Dandan
Hu, Liuhua
Jin, Shuxuan
Yu, Ying
Cai, Zhaohua
Shao, Qin
Shen, Jieyan
Yi, Jing
Xiao, Hua
Shen, Linghong
He, Ben
author_sort Nie, Peng
collection PubMed
description It is well documented that statins protect atherosclerotic patients from inflammatory changes and plaque instability in coronary arteries. However, the underlying mechanisms are not fully understood. Using a previously established mouse model for vulnerable atherosclerotic plaque, we investigated the effect of atorvastatin (10 mg/kg/day) on plaque morphology. Atorvastatin did not lower plasma total cholesterol levels or affect plaque progression at this dosage; however, vulnerable plaque numbers were significantly reduced in the atorvastatin-treated group compared to control. Detailed examinations revealed that atorvastatin significantly decreased macrophage infiltration and subendothelial lipid deposition, reduced intimal collagen content, and elevated collagenase activity and expression of matrix metalloproteinases (MMPs). Because vascular inflammation is largely driven by changes in monocyte/macrophage numbers in the vessel wall, we speculated that the anti-inflammatory effect of atorvastatin may partially result from decreased monocyte recruitment to the endothelium. Further experiments showed that atorvastatin downregulated expression of the chemokines monocyte chemoattractant protein (MCP)-1, chemokine (C-X3-C motif) ligand 1 (CX3CL1) and their receptors CCR2 and, CX3CR1, which are mainly responsible for monocyte recruitment. In addition, levels of the plasma inflammatory markers C-reactive protein (CRP) and tumor necrosis factor (TNF)-α were also significantly decrease in atorvastatin-treated mice. Collectively, our results demonstrate that atorvastatin can improve plaque stability in mice independent of plasma cholesterol levels. Given the profound inhibition of macrophage infiltration into atherosclerotic plaques, we propose that statins may partly exert protective effects by modulating levels of chemokines and their receptors. These findings elucidate yet another atheroprotective mechanism of statins.
format Online
Article
Text
id pubmed-4016207
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-40162072014-05-14 Atorvastatin Improves Plaque Stability in ApoE-Knockout Mice by Regulating Chemokines and Chemokine Receptors Nie, Peng Li, Dandan Hu, Liuhua Jin, Shuxuan Yu, Ying Cai, Zhaohua Shao, Qin Shen, Jieyan Yi, Jing Xiao, Hua Shen, Linghong He, Ben PLoS One Research Article It is well documented that statins protect atherosclerotic patients from inflammatory changes and plaque instability in coronary arteries. However, the underlying mechanisms are not fully understood. Using a previously established mouse model for vulnerable atherosclerotic plaque, we investigated the effect of atorvastatin (10 mg/kg/day) on plaque morphology. Atorvastatin did not lower plasma total cholesterol levels or affect plaque progression at this dosage; however, vulnerable plaque numbers were significantly reduced in the atorvastatin-treated group compared to control. Detailed examinations revealed that atorvastatin significantly decreased macrophage infiltration and subendothelial lipid deposition, reduced intimal collagen content, and elevated collagenase activity and expression of matrix metalloproteinases (MMPs). Because vascular inflammation is largely driven by changes in monocyte/macrophage numbers in the vessel wall, we speculated that the anti-inflammatory effect of atorvastatin may partially result from decreased monocyte recruitment to the endothelium. Further experiments showed that atorvastatin downregulated expression of the chemokines monocyte chemoattractant protein (MCP)-1, chemokine (C-X3-C motif) ligand 1 (CX3CL1) and their receptors CCR2 and, CX3CR1, which are mainly responsible for monocyte recruitment. In addition, levels of the plasma inflammatory markers C-reactive protein (CRP) and tumor necrosis factor (TNF)-α were also significantly decrease in atorvastatin-treated mice. Collectively, our results demonstrate that atorvastatin can improve plaque stability in mice independent of plasma cholesterol levels. Given the profound inhibition of macrophage infiltration into atherosclerotic plaques, we propose that statins may partly exert protective effects by modulating levels of chemokines and their receptors. These findings elucidate yet another atheroprotective mechanism of statins. Public Library of Science 2014-05-09 /pmc/articles/PMC4016207/ /pubmed/24816562 http://dx.doi.org/10.1371/journal.pone.0097009 Text en © 2014 Nie et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Nie, Peng
Li, Dandan
Hu, Liuhua
Jin, Shuxuan
Yu, Ying
Cai, Zhaohua
Shao, Qin
Shen, Jieyan
Yi, Jing
Xiao, Hua
Shen, Linghong
He, Ben
Atorvastatin Improves Plaque Stability in ApoE-Knockout Mice by Regulating Chemokines and Chemokine Receptors
title Atorvastatin Improves Plaque Stability in ApoE-Knockout Mice by Regulating Chemokines and Chemokine Receptors
title_full Atorvastatin Improves Plaque Stability in ApoE-Knockout Mice by Regulating Chemokines and Chemokine Receptors
title_fullStr Atorvastatin Improves Plaque Stability in ApoE-Knockout Mice by Regulating Chemokines and Chemokine Receptors
title_full_unstemmed Atorvastatin Improves Plaque Stability in ApoE-Knockout Mice by Regulating Chemokines and Chemokine Receptors
title_short Atorvastatin Improves Plaque Stability in ApoE-Knockout Mice by Regulating Chemokines and Chemokine Receptors
title_sort atorvastatin improves plaque stability in apoe-knockout mice by regulating chemokines and chemokine receptors
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016207/
https://www.ncbi.nlm.nih.gov/pubmed/24816562
http://dx.doi.org/10.1371/journal.pone.0097009
work_keys_str_mv AT niepeng atorvastatinimprovesplaquestabilityinapoeknockoutmicebyregulatingchemokinesandchemokinereceptors
AT lidandan atorvastatinimprovesplaquestabilityinapoeknockoutmicebyregulatingchemokinesandchemokinereceptors
AT huliuhua atorvastatinimprovesplaquestabilityinapoeknockoutmicebyregulatingchemokinesandchemokinereceptors
AT jinshuxuan atorvastatinimprovesplaquestabilityinapoeknockoutmicebyregulatingchemokinesandchemokinereceptors
AT yuying atorvastatinimprovesplaquestabilityinapoeknockoutmicebyregulatingchemokinesandchemokinereceptors
AT caizhaohua atorvastatinimprovesplaquestabilityinapoeknockoutmicebyregulatingchemokinesandchemokinereceptors
AT shaoqin atorvastatinimprovesplaquestabilityinapoeknockoutmicebyregulatingchemokinesandchemokinereceptors
AT shenjieyan atorvastatinimprovesplaquestabilityinapoeknockoutmicebyregulatingchemokinesandchemokinereceptors
AT yijing atorvastatinimprovesplaquestabilityinapoeknockoutmicebyregulatingchemokinesandchemokinereceptors
AT xiaohua atorvastatinimprovesplaquestabilityinapoeknockoutmicebyregulatingchemokinesandchemokinereceptors
AT shenlinghong atorvastatinimprovesplaquestabilityinapoeknockoutmicebyregulatingchemokinesandchemokinereceptors
AT heben atorvastatinimprovesplaquestabilityinapoeknockoutmicebyregulatingchemokinesandchemokinereceptors